Gastric cancer clinical trials study investigational medications alone, or in combination with other study medications, or standard of care therapy.

Gastric cancer is more commonly known as stomach cancer. About 90% of stomach cancers are adenocarcinomas. This type of cancer starts in the mucus-producing cells in the stomach lining. It expands to the outer layers as it grows.

A gastroesophageal junction adenocarcinoma is a cancer that starts where the stomach connects to the esophagus.

Gastric cancer often reaches advanced stages before it is detected. When this type of cancer reaches the later stages, it is much more difficult to cure.

There is a lot to consider when deciding whether to participate in a clinical trial. Any clinical trial includes risks, which the study doctor will review with you. Make sure you understand the risks before participating.

Resources for patients

For help understanding clinical trial listings and for other resources, visit the Patient Resources section.
Browse resources

About clinical trials

Learn what clinical trials are, how they work, and if you may be eligible to participate.
Learn more
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.